Navigation Links
CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
Date:5/5/2009

CARY, N.C., May 5 /PRNewswire/ -- ASG, Inc., saw continued growth in the first quarter following its acquisition of neighboring Ockham Development Group.

The February merger with the full-service contract research organization sought to expand the breadth and value of services that Cary, North Carolina-based ASG provides clients requiring functional outsourcing and staffing services or the opportunity to outsource an entire clinical trial.

ASG's CEO Jim Baker said, "I am pleased to announce that we continue to make progress in merging the two companies into one."

Through Ockham, ASG has secured new work in the therapeutic areas of oncology, anti-infectives, and vaccines. Ockham has picked up some "significant new business in the last month, and the emerging-growth biotech and pharma market seems to be picking up steam as we move into Q2," Baker said.

In the meantime, Baker indicated that ASG is "answering more functional outsourcing RFPs" and has recently won outsourcing work with one of the company's larger clients.

He also noted a staffing headcount increase over the past 45 days.

In completing the acquisition, ASG's global growth strategy will allow the firm to provide solutions that best meet the needs of existing and potential clients. At the same time, the acquisition will make it possible for Ockham - which will continue to be independently branded - to serve a wider and larger client base.

About ASG:

ASG is a global clinical research service provider of high-quality Contract Research, Functional Outsourcing, and Specialty Staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. Strategically organized to meet the demands of the marketplace, ASG provides flexible solutions that satisfy client needs through highly experienced recruiting and dedicated functional support teams located throughout the world. Staffed by veteran industry professionals with a track record of proven results, it is centrally located near the university-technology-biotech/pharmaceutical sciences nexus known internationally as Research Triangle Park (RTP). http://www.asg-inc.com


'/>"/>
SOURCE ASG, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
4. NxStage Medical Provides Update on Medisystems Acquisition
5. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
6. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
7. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
8. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
9. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
10. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... ... Charm Sciences, Inc. is pleased to announce that its Charm Amphenicol (AMPH) test ... screening test at dairies and farms for raw commingled cow milk. The test was ... system. These systems are a combination incubator and reader in one. , “The AMPH ...
(Date:6/20/2017)... ... ... Biologist Dawn Maslar MS has found a biomarker that she claims verifies ... The Neuroscience of Meeting, Dating, Losing Your Mind, and Finding True Love, Maslar found ... step, in my estimation, was to scientifically track the evidence of commitment in men,” ...
(Date:6/20/2017)... 2017  Kibow Biotech Inc., a pioneer in developing ... of a new patent covering a unique method for ... Patent and Trademark Office on May 23 rd ... of Bio award in 2014 in San ... approaches to chronic disease. Renadyl™, the first and only ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... Do More ... the transition from being a trusted supplier in the weighing industry, to extending its ... extractions, ELISA essays, enzyme reactions, immunoassays, hybridizations and more, allowing for its customers ...
Breaking Biology Technology:
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
Breaking Biology News(10 mins):